Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1147-1160
Open Access | Times Cited: 22

Showing 22 citing articles:

Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval
Hee Sun Choi, A Young Choi, Jeffrey B. Kopp, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 14
Open Access | Times Cited: 6
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps
Bruna M. Silva, Giovanni Freitas Gomes, Flávio P. Veras, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 14
Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2
Ana C. Puhl, André S. Godoy, G.D. Noske, et al.
ACS Omega (2023) Vol. 8, Iss. 25, pp. 22603-22612
Open Access | Times Cited: 11
In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
Eslam A. R. Mohamed, Islam M. Abdel-Rahman, Magdi E. A. Zaki, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 3
Open Access | Times Cited: 9
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning
K. Eurídice Juárez‐Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 240-240
Open Access | Times Cited: 2
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial
Nomathemba Chandiwana, Chelsea Kruger, Hilary Johnstone, et al.
EBioMedicine (2022) Vol. 86, pp. 104322-104322
Open Access | Times Cited: 14
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
ACS Omega (2022) Vol. 7, Iss. 36, pp. 31935-31944
Open Access | Times Cited: 13
SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads
Arun K. Ghosh, Dana Shahabi, Mackenzie E.C. Imhoff, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 96, pp. 129489-129489
Open Access | Times Cited: 7
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors
Ana C. Puhl, Melina Mottin, Carolina Q. Sacramento, et al.
ACS Omega (2022) Vol. 7, Iss. 32, pp. 27950-27958
Open Access | Times Cited: 9
Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
Gianfranco Sabadini, Marco Mellado, Cesar A. Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 606-606
Open Access | Times Cited: 1
PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies
Nada Abla, Lisa M. Almond, Jennifer J. Bonner, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 1
Application of Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung and Trachea Exposure of Pyronaridine and Artesunate in Hamsters
Dong‐Wook Kang, Kyung Min Kim, Ju Hee Kim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 838-838
Open Access | Times Cited: 4
Multiple approaches to repurposing drugs for neuroblastoma
Laura Rank, Ana C. Puhl, Tammy M. Havener, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117043-117043
Open Access | Times Cited: 7
Learning from COVID-19: How drug hunters can prepare for the next pandemic
Ana C. Puhl, Thomas R. Lane, Sean Ekins
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103723-103723
Open Access | Times Cited: 3
Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
Patricia A. Vignaux, Thomas R. Lane, Ana C. Puhl, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 12532-12537
Open Access | Times Cited: 2
Pyronaridine tetraphosphate is an efficacious antiviral and anti-inflammatory active against multiple highly pathogenic coronaviruses
Jeremy Ardanuy, Robert M. Johnson, Carly Dillen, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 2
Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
Thane Jones, Natalia Monakhova, Florence Guivel‐Benhassine, et al.
ACS Omega (2023) Vol. 8, Iss. 43, pp. 40817-40822
Open Access | Times Cited: 2
Oral Pyronaridine Tetraphosphate Reduces Tissue Presence of Parasites in a Mouse Model of Chagas Disease
Jair L. Siqueira-Neto, Thomas R. Lane, Jean Bernatchez, et al.
ACS Omega (2024) Vol. 9, Iss. 35, pp. 37288-37298
Open Access
High-Throughput Empirical and Virtual Screening to Discover Novel Inhibitors of Polyploid Giant Cancer Cells in Breast Cancer
Yushu Ma, Chien-Hung Shih, Jinxiong Cheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Drug repurposing for hard-to-treat human alveolar echinococcosis: pyronaridine and beyond
Weisi Wang, Jun Li, Wenjing Qi, et al.
Parasitology (2024), pp. 1-8
Open Access
Exploring the druggability of the UEV domain of human TSG101 in search for broad-spectrum antivirals
Fernando Montero, Marisa Parra‐López, Alejandro Rodríguez‐Martínez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Exploring the druggability of the UEV domain of human TSG101 in search for broad‐spectrum antivirals
Fernando Montero, Marisa Parra‐López, Alejandro Rodríguez‐Martínez, et al.
Protein Science (2024) Vol. 34, Iss. 1
Open Access
Page 1

Scroll to top